J Sun, H Yao, X Ren, L Cui, L Liu,
G Wang, Z Tang - Nano Letters, 2024 - ACS Publications
Immune checkpoint inhibitor (ICI) therapy is effectively employed in treating various
malignancies. However, the response rate is constrained to 5–30%, which is attributed to …